This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

William J. Catalona, MD; Deborah S. Smith, PhD
Washington University School of Medicine St Louis, Mo

JAMA. 1996;275(11):838.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We agree with Dr Bangma and colleagues that additional study is required to determine whether measurement of the percentage of free PSA is the best method for increasing the specificity of PSA screening for prostate cancer detection. Although our study is preliminary, it is encouraging that our results are consistent with reports of other investigators from around the world who have used different study methods and assays.^1-3 In the study by Bangma et al,⁴ using still another assay in men with PSA levels of 4 to 10 ng/mL, a cutoff of 28% free PSA would have detected 91% of cancers and eliminated 19% of negative biopsies; in the subset with a gland volume less than 50 cm³, a cutoff of 19% would have detected 91% of the cancers and eliminated 49% of negative biopsies. The reason for the lower specificity in the study by Bangma . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?